On the basis of numerous studies with small sample size and the different methylation frequencies, we carried out this meta‐analysis to better determine the relationship between the methylation of the MGMT promoter and ovarian cancer in the comparison of cancer and different control groups. The gene discussed is MGMT; the disease is ovarian carcinoma.